Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 1999 Jun;76(6):2871–2878. doi: 10.1016/S0006-3495(99)77442-4

An atomic model for the pleated beta-sheet structure of Abeta amyloid protofilaments.

L Li 1, T A Darden 1, L Bartolotti 1, D Kominos 1, L G Pedersen 1
PMCID: PMC1300259  PMID: 10354415

Abstract

Synchrotron x-ray studies on amyloid fibrils have suggested that the stacked pleated beta-sheets are twisted so that a repeating unit of 24 beta-strands forms a helical turn around the fibril axis (. J. Mol. Biol. 273:729-739). Based on this morphological study, we have constructed an atomic model for the twisted pleated beta-sheet of human Abeta amyloid protofilament. In the model, 48 monomers of Abeta 12-42 stack (four per layer) to form a helical turn of beta-sheet. Each monomer is in an antiparallel beta-sheet conformation with a turn located at residues 25-28. Residues 17-21 and 31-36 form a hydrophobic core along the fibril axis. The hydrophobic core should play a critical role in initializing Abeta aggregation and in stabilizing the aggregates. The model was tested using molecular dynamics simulations in explicit aqueous solution, with the particle mesh Ewald (PME) method employed to accommodate long-range electrostatic forces. Based on the molecular dynamics simulations, we hypothesize that an isolated protofilament, if it exists, may not be twisted, as it appears to be when in the fibril environment. The twisted nature of the protofilaments in amyloid fibrils is likely the result of stabilizing packing interactions of the protofilaments. The model also provides a binding mode for Congo red on Abeta amyloid fibrils. The model may be useful for the design of Abeta aggregation inhibitors.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benzinger T. L., Gregory D. M., Burkoth T. S., Miller-Auer H., Lynn D. G., Botto R. E., Meredith S. C. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13407–13412. doi: 10.1073/pnas.95.23.13407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Betz S. F., Liebman P. A., DeGrado W. F. De novo design of native proteins: characterization of proteins intended to fold into antiparallel, rop-like, four-helix bundles. Biochemistry. 1997 Mar 4;36(9):2450–2458. doi: 10.1021/bi961704h. [DOI] [PubMed] [Google Scholar]
  3. Blake C. C., Geisow M. J., Oatley S. J., Rérat B., Rérat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol. 1978 May 25;121(3):339–356. doi: 10.1016/0022-2836(78)90368-6. [DOI] [PubMed] [Google Scholar]
  4. Blake C., Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure. 1996 Aug 15;4(8):989–998. doi: 10.1016/s0969-2126(96)00104-9. [DOI] [PubMed] [Google Scholar]
  5. Burgevin M. C., Passat M., Daniel N., Capet M., Doble A. Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones. Neuroreport. 1994 Dec 20;5(18):2429–2432. doi: 10.1097/00001756-199412000-00006. [DOI] [PubMed] [Google Scholar]
  6. Carter D. B., Chou K. C. A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils. Neurobiol Aging. 1998 Jan-Feb;19(1):37–40. doi: 10.1016/s0197-4580(97)00164-4. [DOI] [PubMed] [Google Scholar]
  7. Caughey B., Ernst D., Race R. E. Congo red inhibition of scrapie agent replication. J Virol. 1993 Oct;67(10):6270–6272. doi: 10.1128/jvi.67.10.6270-6272.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chaney M. O., Webster S. D., Kuo Y. M., Roher A. E. Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. Protein Eng. 1998 Sep;11(9):761–767. doi: 10.1093/protein/11.9.761. [DOI] [PubMed] [Google Scholar]
  9. Chou K. C., Maggiora G. M., Némethy G., Scheraga H. A. Energetics of the structure of the four-alpha-helix bundle in proteins. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4295–4299. doi: 10.1073/pnas.85.12.4295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coles M., Bicknell W., Watson A. A., Fairlie D. P., Craik D. J. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 1998 Aug 4;37(31):11064–11077. doi: 10.1021/bi972979f. [DOI] [PubMed] [Google Scholar]
  11. Cooper J. H. Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods. Lab Invest. 1974 Sep;31(3):232–238. [PubMed] [Google Scholar]
  12. DeLellis R. A., Glenner G. G., Ram J. S. Histochemical observations on amyloid with reference to polarization microscopy. J Histochem Cytochem. 1968 Oct;16(10):663–665. doi: 10.1177/16.10.663-a. [DOI] [PubMed] [Google Scholar]
  13. Dill K. A. Dominant forces in protein folding. Biochemistry. 1990 Aug 7;29(31):7133–7155. doi: 10.1021/bi00483a001. [DOI] [PubMed] [Google Scholar]
  14. Fraser P. E., Nguyen J. T., Surewicz W. K., Kirschner D. A. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J. 1991 Nov;60(5):1190–1201. doi: 10.1016/S0006-3495(91)82154-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  16. Hamaguchi N., Charifson P., Darden T., Xiao L., Padmanabhan K., Tulinsky A., Hiskey R., Pedersen L. Molecular dynamics simulation of bovine prothrombin fragment 1 in the presence of calcium ions. Biochemistry. 1992 Sep 22;31(37):8840–8848. doi: 10.1021/bi00152a021. [DOI] [PubMed] [Google Scholar]
  17. Harper J. D., Lieber C. M., Lansbury P. T., Jr Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol. 1997 Dec;4(12):951–959. doi: 10.1016/s1074-5521(97)90303-3. [DOI] [PubMed] [Google Scholar]
  18. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol. 1991 Mar 5;218(1):149–163. doi: 10.1016/0022-2836(91)90881-6. [DOI] [PubMed] [Google Scholar]
  19. Inouye H., Fraser P. E., Kirschner D. A. Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction. Biophys J. 1993 Feb;64(2):502–519. doi: 10.1016/S0006-3495(93)81393-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jarrett J. T., Berger E. P., Lansbury P. T., Jr The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 1993 May 11;32(18):4693–4697. doi: 10.1021/bi00069a001. [DOI] [PubMed] [Google Scholar]
  21. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  22. Kelly J. W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol. 1998 Feb;8(1):101–106. doi: 10.1016/s0959-440x(98)80016-x. [DOI] [PubMed] [Google Scholar]
  23. Kirschner D. A., Inouye H., Duffy L. K., Sinclair A., Lind M., Selkoe D. J. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6953–6957. doi: 10.1073/pnas.84.19.6953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Klunk W. E., Pettegrew J. W., Abraham D. J. Two simple methods for quantifying low-affinity dye-substrate binding. J Histochem Cytochem. 1989 Aug;37(8):1293–1297. doi: 10.1177/37.8.2666512. [DOI] [PubMed] [Google Scholar]
  25. Kusumoto Y., Lomakin A., Teplow D. B., Benedek G. B. Temperature dependence of amyloid beta-protein fibrillization. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12277–12282. doi: 10.1073/pnas.95.21.12277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Langosch D., Heringa J. Interaction of transmembrane helices by a knobs-into-holes packing characteristic of soluble coiled coils. Proteins. 1998 May 1;31(2):150–159. doi: 10.1002/(sici)1097-0134(19980501)31:2<150::aid-prot5>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  27. Lansbury P. T., Jr, Costa P. R., Griffiths J. M., Simon E. J., Auger M., Halverson K. J., Kocisko D. A., Hendsch Z. S., Ashburn T. T., Spencer R. G. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol. 1995 Nov;2(11):990–998. doi: 10.1038/nsb1195-990. [DOI] [PubMed] [Google Scholar]
  28. Lansbury P. T., Jr In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. Biochemistry. 1992 Aug 4;31(30):6865–6870. doi: 10.1021/bi00145a001. [DOI] [PubMed] [Google Scholar]
  29. Lazo N. D., Downing D. T. Amyloid fibrils may be assembled from beta-helical protofibrils. Biochemistry. 1998 Feb 17;37(7):1731–1735. doi: 10.1021/bi971016d. [DOI] [PubMed] [Google Scholar]
  30. Lee J. P., Stimson E. R., Ghilardi J. R., Mantyh P. W., Lu Y. A., Felix A. M., Llanos W., Behbin A., Cummings M., Van Criekinge M. 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry. 1995 Apr 18;34(15):5191–5200. doi: 10.1021/bi00015a033. [DOI] [PubMed] [Google Scholar]
  31. Li L., Darden T. A., Freedman S. J., Furie B. C., Furie B., Baleja J. D., Smith H., Hiskey R. G., Pedersen L. G. Refinement of the NMR solution structure of the gamma-carboxyglutamic acid domain of coagulation factor IX using molecular dynamics simulation with initial Ca2+ positions determined by a genetic algorithm. Biochemistry. 1997 Feb 25;36(8):2132–2138. doi: 10.1021/bi962250r. [DOI] [PubMed] [Google Scholar]
  32. Lomakin A., Chung D. S., Benedek G. B., Kirschner D. A., Teplow D. B. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1125–1129. doi: 10.1073/pnas.93.3.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lorenzo A., Yankner B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12243–12247. doi: 10.1073/pnas.91.25.12243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mager P. P. Molecular simulation of the primary and secondary structures of the Abeta(1-42)-peptide of Alzheimer's disease. Med Res Rev. 1998 Nov;18(6):403–430. doi: 10.1002/(sici)1098-1128(199811)18:6<403::aid-med4>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  35. Malinchik S. B., Inouye H., Szumowski K. E., Kirschner D. A. Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys J. 1998 Jan;74(1):537–545. doi: 10.1016/S0006-3495(98)77812-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pauling L., Corey R. B. Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets. Proc Natl Acad Sci U S A. 1951 Nov;37(11):729–740. doi: 10.1073/pnas.37.11.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pike C. J., Overman M. J., Cotman C. W. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem. 1995 Oct 13;270(41):23895–23898. doi: 10.1074/jbc.270.41.23895. [DOI] [PubMed] [Google Scholar]
  38. Pike C. J., Walencewicz A. J., Glabe C. G., Cotman C. W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991 Nov 1;563(1-2):311–314. doi: 10.1016/0006-8993(91)91553-d. [DOI] [PubMed] [Google Scholar]
  39. Pollack S. J., Sadler I. I., Hawtin S. R., Tailor V. J., Shearman M. S. Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion. Neurosci Lett. 1995 Sep 15;197(3):211–214. doi: 10.1016/0304-3940(95)11939-t. [DOI] [PubMed] [Google Scholar]
  40. Selkoe D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem. 1996 Aug 2;271(31):18295–18298. doi: 10.1074/jbc.271.31.18295. [DOI] [PubMed] [Google Scholar]
  41. Serpell L. C., Sunde M., Fraser P. E., Luther P. K., Morris E. P., Sangren O., Lundgren E., Blake C. C. Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J Mol Biol. 1995 Nov 24;254(2):113–118. doi: 10.1006/jmbi.1995.0604. [DOI] [PubMed] [Google Scholar]
  42. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol. 1994 Mar;45(3):373–379. [PubMed] [Google Scholar]
  43. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron. 1994 Jan;12(1):219–234. doi: 10.1016/0896-6273(94)90165-1. [DOI] [PubMed] [Google Scholar]
  44. Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K., Frank R. W., Rösch P. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur J Biochem. 1995 Oct 1;233(1):293–298. doi: 10.1111/j.1432-1033.1995.293_1.x. [DOI] [PubMed] [Google Scholar]
  45. Sunde M., Serpell L. C., Bartlam M., Fraser P. E., Pepys M. B., Blake C. C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol. 1997 Oct 31;273(3):729–739. doi: 10.1006/jmbi.1997.1348. [DOI] [PubMed] [Google Scholar]
  46. Tjernberg L. O., Näslund J., Lindqvist F., Johansson J., Karlström A. R., Thyberg J., Terenius L., Nordstedt C. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem. 1996 Apr 12;271(15):8545–8548. doi: 10.1074/jbc.271.15.8545. [DOI] [PubMed] [Google Scholar]
  47. Turnell W. G., Finch J. T. Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. J Mol Biol. 1992 Oct 20;227(4):1205–1223. doi: 10.1016/0022-2836(92)90532-o. [DOI] [PubMed] [Google Scholar]
  48. Walsh D. M., Lomakin A., Benedek G. B., Condron M. M., Teplow D. B. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem. 1997 Aug 29;272(35):22364–22372. doi: 10.1074/jbc.272.35.22364. [DOI] [PubMed] [Google Scholar]
  49. Wood S. J., Wetzel R., Martin J. D., Hurle M. R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry. 1995 Jan 24;34(3):724–730. doi: 10.1021/bi00003a003. [DOI] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES